JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Farah, A.
Right arrow Articles by Koda, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farah, A.
Right arrow Articles by Koda, F.
Journal of Pharmacology And Experimental Therapeutics, Vol. 108, Issue 4, 410-423, 1953
Copyright © 1953 by American Society for Pharmacology and Experimental Therapeutics


THE ACTION OF SODIUM FLUOROACETATE ON THE RENAL TUBULAR TRANSPORT OF PARA-AMINOHIPPURATE AND GLUCOSE IN THE DOG

A. Farah 1, G. Graham 1, and F. Koda 1

1 Department of Pharmacology, State University of New York, Upstate Medical Center, Syracuse 10, New York

In anesthetized dogs sodium fluoroacetate (NaFAc) reduced renal blood flow, para-aminohippurate, (R.P.F.), creatinine and inulin clearance (GFR) as well as para-aminohippurate and glucose transport maximum (PAH Tm, glucose Tm). Infusions of sodium acetate increased PAH Tm and protected against the effects of sodium fluoroacetate on the PAH secretory mechanism. Once fluoroacetate effects had occurred acetate had no stimulatory effect on PAH Tm. The evidence presented suggests a competitive mechanism between NaFAc and sodium acetate on the PAH secretory mechanism. Kidney slices from fluoroacetate poisoned dogs show a reduction in their ability to concentrate PAH both in the absence and presence of sodium acetate as substrate.

Glucose Tm is reduced by fluoroacetate administration. It differs from the PAH secretory mechanism in that sodium acetate does not protect the glucose reabsorptive mechanism against sodium fluoroacetate effects. The renal hemodynamic changes produced by NaFAc make it difficult to interpret these effects on glucose Tm. It is possible that a part of the fluoroacetate induced reduction in glucose Tm is due to a blocking of renal tubular reabsorption of glucose.

Submitted on February 16, 1953







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1953 by the American Society for Pharmacology and Experimental Therapeutics.